Zobrazeno 1 - 10
of 3 915
pro vyhledávání: '"High-Cost"'
Autor:
Sagoo GS; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK., Robinson T; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK., Coughlan D; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK., Meader N; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK., Rice S; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK., Vale L; Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK.
Publikováno v:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2023 Jul-Dec; Vol. 23 (10), pp. 1177-1183. Date of Electronic Publication: 2023 Nov 13.
Autor:
Desai GS; Department of Obstetrics and Gynecology, Seth GS Medical College and King Edward Memorial Hospital, Mumbai, India. gdesai83@gmail.com.
Publikováno v:
Journal of robotic surgery [J Robot Surg] 2018 Dec; Vol. 12 (4), pp. 725-726. Date of Electronic Publication: 2018 Jun 04.
Publikováno v:
Archives of Public Health, Vol 82, Iss 1, Pp 1-10 (2024)
Abstract Background High-need, high-cost (HNHC) patients are a major focus of international healthcare reform. However, research on HNHC children in China remains limited. This study aims to classify HNHC pediatric patients, analyze the differences a
Externí odkaz:
https://doaj.org/article/7f9075166dd747178a9cd455fab0d05f
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 16, Pp 827-837 (2024)
Adilet Nazarbayev,1 Ardak Nurbakyt,1 Bibigul Omirbayeva,2 Anuar Akhmetzhan,1 Lyazzat Kosherbayeva1,3 1Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan; 2Salidat Kairbekova National Research Center for Health Development, Astana, Ka
Externí odkaz:
https://doaj.org/article/bd3850d62f924ae49a0286db80ddc098
Autor:
Driscoll D; DCi Biotech Inc. and DCi Biotech Pty Ltd., Perth, Australia., Farnia S; American Society for Blood and Marrow Transplantation, Arlington Heights, Illinois, USA., Kefalas P; Cell and Gene Therapy Catapult Limited, London, United Kingdom., Maziarz RT; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
Publikováno v:
Stem cells translational medicine [Stem Cells Transl Med] 2017 Aug; Vol. 6 (8), pp. 1723-1729.
Autor:
Yin, Jing
Publikováno v:
Journal of Hospitality and Tourism Insights, 2023, Vol. 7, Issue 4, pp. 1890-1910.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/JHTI-04-2023-0268
Autor:
Picharee Karunayawong, Piyada Gaewkhiew, Myka Harun Sarajan, Chulathip Boonma, Rukmanee Butchon, Jarawee Sukmanee, Thanayut Saeraneesopon, Yot Teerawattananon, Wanrudee Isaranuwatchai
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background The phenomenon of high-cost users (HCUs) in health care occurs when a small proportion of patients account for a large proportion of health care expenditures. By understanding this phenomenon during the COVID-19 pandemic, tailored
Externí odkaz:
https://doaj.org/article/94fe5ae0df1842a0a0f117ff9dad9ef6
Autor:
Feinberg DT; Geisinger Health System, Danville, Pennsylvania., McClellan MB; Duke University, Durham, North Carolina.
Publikováno v:
JAMA [JAMA] 2016 Oct 25; Vol. 316 (16), pp. 1653-1654.
Autor:
Bianco, Anthony
Publikováno v:
BusinessWeek. 2/13/2006, Issue 3971, p78-81. 4p. 3 Color Photographs.
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Background Drug expenditure is an important part of health expenditure. Managed Entry Agreement (MEA) is a common strategy implemented in many countries, such as the United States, the United Kingdom, and the European countries to control drug expend
Externí odkaz:
https://doaj.org/article/2c0a887906894b24885a96e55fbc98e8